English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Developed pharmaceutical composition based on two innovative chitosan-containing substances: the chitosan-chymopsin complex and the chitosan-miramistin complex, for the treatment of infected wounds in gel dosage form for external use has four types of pharmacological effects necrolytic, antimicrobial, wound healing and analgesic. The chitosan-chymopsin complex provides prolonged proteolytic action of the enzyme, restores microcirculation in wound walls, improves metabolic processes and relieves local inflammation. The chitosan-miramistin complex has a pronounced bactericidal effect against aerobic and anaerobic bacteria, gram-positive and gram-negative microorganisms, both in the form of monocultures and in the form of associations, including hospital strains with antibiotic resistance. Gel as a dosage form provides indirect anaesthetic effect due to cooling effect when applied to the damaged surface.

Pharmaceutical Composition Based on Two Innovative Chitosan-Containing Substances – The Chitosan-Chymopsin Complex and the Chitosan-Miramistin Complex – for Production of a Finished Dosage Form for the Treatment of Infected Wounds of Various Origins